Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients

BACKGROUND: Hypokalemia is common in peritoneal dialysis (PD) patients and is associated with increased cardiovascular and all-cause mortality. The management approach for such patients routinely includes spironolactone at our centre. We undertook this study to assess the efficacy of spironolactone...

Descripción completa

Detalles Bibliográficos
Autores principales: Langote, Amit, Hiremath, Swapnil, Ruzicka, Marcel, McCormick, Brendan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681284/
https://www.ncbi.nlm.nih.gov/pubmed/29125879
http://dx.doi.org/10.1371/journal.pone.0187269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681284/
https://www.ncbi.nlm.nih.gov/pubmed/29125879
http://dx.doi.org/10.1371/journal.pone.0187269

Ejemplares similares